Qube Research & Technologies Ltd - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 20 filers reported holding CALLIDITAS THERAPEUTICS AB in Q1 2024. The put-call ratio across all filers is 21.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q2 2024$663
-57.5%
17
-76.4%
0.00%
Q1 2024$1,559
-16.0%
720.0%0.00%
Q4 2023$1,855
+41.1%
720.0%0.00%
Q3 2023$1,315720.00%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q1 2024
NameSharesValueWeighting ↓
BVF INC/IL 750,000$16,215,0000.63%
IRONWOOD INVESTMENT MANAGEMENT LLC 27,836$602,0000.31%
Pentwater Capital Management LP 46,000$995,0000.01%
DEUTSCHE BANK AG\ 71,531$1,547,0000.00%
MORGAN STANLEY 2,005$43,0000.00%
Renaissance Technologies 13,600$294,0000.00%
HOWLAND CAPITAL MANAGEMENT LLC 10,000$00.00%
BANK OF AMERICA CORP /DE/ 193$4,0000.00%
WELLS FARGO & COMPANY/MN 284$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders